14.3 C
New York
Tuesday, March 21, 2023

Today, Zentalis Pharmaceuticals Inc. (NASDAQ: ZNTL) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Zentalis Pharmaceuticals Inc. (ZNTL) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $23.50. The Zentalis Pharmaceuticals Inc. has recorded 21,905 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $23.50 and fluctuated between $23.85 as its day high and $22.89 as its day low. The current market capitalization of Zentalis Pharmaceuticals Inc. is $1.31B. A total of 0.51 million shares were traded on the day, compared to an average of 556.10K shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ZNTL has seen 0 BUY and 7 SELL insider trades, representing the acquisition of 0 and the disposition of 47,374 shares. Over the last 12 months, there were 14 BUYs and 83 SELLs from insiders. Insiders purchased 526,215 shares during that period but sold 339,594.

In the most recent transaction, Gallagher Cam sold 10,000 shares of ZNTL for 24.15 per share on Jan 17. After the transaction, the President now owns 352,011 company shares. In a previous transaction on Jan 05, Gallagher Cam sold 10,000 shares at 21.02 per share. ZNTL shares that President owns now total 362,011.

Among the insiders who sold shares, Gallagher Cam disposed of 12,500 shares on Nov 15 at a per-share price of $22.77. This resulted in the President holding 372,011 shares of ZNTL after the transaction. In another insider transaction, Gallagher Cam sold 12,374 shares at $23.56 per share on Nov 08. Company shares held by the President now total 384,511.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ZNTL in the last 3 months, the mean price target is $52.30 with high estimates of $120.00 and low estimates of $27.00. In terms of 52-week highs and lows, ZNTL has a high of $59.65 and a low of $17.33.

As of this writing, ZNTL has an earnings estimate of -$1.17 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$1.01 per share and a lower estimate of -$1.41. The company reported an EPS of -$1.31 in the last quarter, which was -8.30% lower than expectations of -$1.21.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 11 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZNTL is Hold with a score of 5.00. A total of 11 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles